NasdaqGS:RGENLife Sciences
Is Repligen (RGEN) Offering Value After A 28.5% Year To Date Share Price Decline
If you are wondering whether Repligen at around US$117 a share offers good value or hidden risks, the next sections break down what the current price may be implying.
The stock has had a mixed run, with a 6.6% gain over the last 30 days, set against a 28.5% decline year to date and a 15.8% decline over the past year.
These moves sit within a broader three year return of 25.3% decline and a five year return of 39.7% decline. This can influence how the market currently views the stock's risk...